A part from canonical G protein-mediated signaling, G protein-coupled receptors (GPCRs) also activate noncanonical G protein-independent pathways, frequently mediated by b-arrestins (1, 2). So-called "biased" GPCR agonists differentially activate signaling pathways with distinct efficacies and potencies as compared with unbiased agonists that activate both pathways equally (3) . This preferential activation of one pathway over the other has been termed "functional selectivity" or "signaling bias" (2) (3) (4) (5) . Depending on the receptor, biased signaling patterns are key for mediating inflammation (6) , apoptosis (7) , and many other processes (2) . Biased ligands have been proposed to stabilize receptor conformations that are distinct from those induced by unbiased ligands and selectively change the propensity of GPCR coupling to either G proteins or b-arrestins (2) .
Agonist-induced changes in trigger motifs of GPCRs (8) near the binding pocket facilitate large-scale helical movements that are accompanied by rearrangements in highly conserved residues called "microswitches" (9) that prime GPCRs for subsequent G protein binding and activation (10) . The structural features of a signaling-biased receptor state remain elusive, and although complexes of two b-arrestin-biased ligands with the b 1 -adrenergic receptor (b 1 AR) have recently been solved (11), they did not reveal activationrelated changes in the receptor.
To elucidate molecular and structural details of biased signaling, we characterized G proteinand b-arrestin-mediated signaling at G proteincoupled serotonin [5-hydroxytryptamine (5-HT)] receptors with several representative ergolines, such as lysergic acid diethylamide (LSD) and ergotamine (ERG). Additionally, we solved the crystal structure of the 5-HT 2B receptor in complex with ERG, which was identified as a highly biased agonist for the 5-HT 2B receptor (12) .
To investigate potential differences of ergoline signaling at 5-HT receptors, we examined three prototypical serotonin receptors that interact with distinct G proteins. The 5-HT 1B receptor inhibits cyclic adenosine monophosphate (cAMP) production through G i , the 5-HT 2B receptor mediates phospholipase C activation through G q , and the 5-HT 7A receptor stimulates cAMP production through G s (13) . We compared G proteinand b-arrestin-mediated signaling at cloned human 5-HT 1B and 5-HT 2B receptors and G proteinmediated signaling at 5-HT 7A receptors stimulated by selective and nonselective ligands in human embryonic kidney (HEK) 293 cells ( Fig. 1 and table S1) (14) .
LSD and, especially, ERG displayed bias for b-arrestin signaling at 5-HT 2B (bias factors 101 and 228, respectively) ( Fig. 1D) , minimal bias at 5-HT 1B (bias factors 5 and 25, respectively) (Fig.  1D) , and G protein antagonism at 5-HT 7A receptors ( Fig. 1B and table S1 ). We also found significant b-arrestin signaling bias for other ergolines-such as dihydroergotamine (DHE), methylergonovine (MTE), pergolide (PER), and cabergoline (CAB)-at the 5-HT 2B receptor, whereas all other evaluated compounds showed no significant bias (Fig. 1D ). ERG and DHE, both of which contain a large tripeptide moiety substitution at the amide scaffold, displayed more extreme signaling bias at the 5-HT 2B receptor compared with LSD.
To investigate the molecular details responsible for biased signaling, we crystallized an engineered 5-HT 2B receptor construct in complex with ERG, solved its structure at 2.7 Å ( fig. S1 and S2 and table S3), and compared it with the structure of 5-HT 1B /ERG reported in the companion manuscript (15) , as well as to other known unbiased active-state GPCR structures. Residues P 5.50 , I 3.40 , and F 6.44 (16, 17) , the "P-I-F" motif (P, Pro; I, Ile; F, Phe), form an interface between helices V, III, and VI near the base of the ligand binding pocket in b 2 AR and many other aminergic receptors, including all 5-HT GPCRs. In the active-state structures of b 2 AR (8, 18), a chain of conformational rearrangements occurs in the P-I-F residues, in which an inward shift of helix V residue P211 5.50 is coupled with: (i) a rotamer switch in I121 3.40 , (ii) a large movement of the F282 6 .44 side chain, and (iii) a corresponding rotation of helix VI on the cytoplasmic side (8) . The 5-HT 1B and 5-HT 2B receptor structures display two different conformations of the P-I-F motif (Fig. 2) . For the 5-HT 1B receptor, we observe that the P-I-F configuration is essentially identical to that of the active-state of b 2 AR [b 2 AR-R*, Protein Data Bank identification number (PDB ID): 3SN6 (18)] (Fig. 2B) . Whereas the 5-HT 2B receptor adopts a similar active-like conformation of P229
5.50 and I143 3.40 , the sidechain conformation of F333 6 .44 was similar to that observed in the inactive b 2 AR [b 2 AR-R, PDB ID: 2RH1 (19)] (Fig. 2C and fig. S2B ). The P-I-F motif, therefore, appears to be in an active-like conformation in the 5-HT 1B structure, but only in an intermediate active conformation in the 5-HT 2B receptor structure.
At the cytoplasmic side of the receptors, GPCR activation is generally characterized by the displacement of helices V, VI, and VII (10) . The magnitude of the helical motions depends on the activation-state; for example, the outward displacement of the intracellular tip of helix VI ranges between 3 and 14 Å, whereas helix VII shifts between 3 to 5 Å toward the receptor core (10, (18) (19) (20) (21) (22) . These concerted rearrangements induce an opening of the helical bundle at the cytoplasmic side, which facilitates the binding and subsequent activation of G proteins. Analysis of the 5-HT 1B and 5-HT 2B receptor structures shows that the conformation in the intracellular half of the helical bundle is notably shifted toward that seen in active-state GPCR structures ( Fig. 3 and figs. S3 and S4) and is distinct from those of inactive-state GPCR structures ( Fig. 3 and figs. S5 and S6). In the 5-HT 1B and 5-HT 2B receptor structures, the helix VI intracellular part is located at least 2 to 4 Å further away from the receptor core than in the inactivestate structures of other aminergic GPCRs ( fig.  S5 ). This conformation of helix VI is close to the one observed in active-state structures of the A 2A adenosine receptor (A 2A AR) ( fig. S3 ) and rhodopsin (Rho) ( fig. S4 ), though the outward shift of the helix is smaller in magnitude compared with that of the G protein-bound b 2 AR (Fig. 3, A and C) . The only difference that we observed in helix VI between 5-HT receptor subtypes was a small clockwise rotation in the 5-HT 1B receptor toward the active state that is absent in the 5-HT 2B structure (Figs. 2, B and C, and 3, A and C). Helix VII in both 5-HT receptor structures also displays intermediate active states when compared with b 2 AR (Fig. 3, B and D), where it is shifted toward the receptor core as compared with inactive-state structures of other aminergic GPCRs (fig. S6 ). Whereas the 5-HT 2B /ERG receptor structure shows less pronounced active-like changes in helix VI, helix VII appears to be in a more active conformation than it is in the 5-HT 1B /ERG receptor structure (Fig. 3, B and D) .
Another important aspect of GPCR activation is the rearrangement of side chains in highly conserved motifs D(E)/RY (helix III) and NPxxY (helix VII) (D, Asp; E, Glu; R, Arg; Y, Tyr; N, Asn; x, any amino acid), which are referred to as microswitches (9) . Thus, the D(E)/RY motif 3.49 in the 5-HT 2B receptor structure, but it is broken in the 5-HT 1B receptor structure (Fig. 4, A, B, and D; and fig. S2C ). In the 5-HT 1B receptor structure, the D146 3.49 side chain forms a hydrogen bond to Y157 in intracellular loop 2, and the R147 3.50 side chain interacts with the main-chain carbonyl in a loop of the fusion protein BRIL (residue L1048; L, Leu), which is partially inserted into the G protein binding crevice (Fig. 4A) . Thus, the conformation of the D (E)RY motif mimics the active state of b 2 AR in the 5-HT 1B structure but resembles the inactive state in the 5-HT 2B structure (Fig. 4, A and C; and fig. S7 ).
The highly conserved NPxxY motif at the cytoplasmic end of helix VII is another key microswitch of GPCR activation (9) . Upon GPCR activation, the intracellular end of helix VII moves toward the receptor core, and a rotation of Y 7.53 around the helical axis moves the side chain further into the seven-transmembrane (TM) bundle (10) . Both 5-HT receptor structures show activestate conformations of the NPxxY motif when compared with b 2 AR, A 2A AR, and Rho (Fig. 4, D and E; and figs. S2D and S7), with more pronounced activation features in the 5-HT 2B receptor.
Our analysis indicates that the 5-HT 1B /ERG structure has most of the attributes of a classical agonist-induced, active-like state, consistent with our biochemical findings that ERG is a comparatively unbiased agonist at the 5-HT 1B receptor. In contrast, the 5-HT 2B /ERG structure exhibits conformational characteristics of both the active and inactive states. The structure of b 2 AR-Gabg complex, along with recent nuclear magnetic resonance and fluorescence studies of b 2 AR, implicates helix VI predominantly in G protein signaling, whereas conformational changes in helix VII are associated with enhanced b-arrestin signaling (18, 23, 24) . Thus, an active-like state in the helix VII conformation of the 5-HT 2B receptor, but only partial changes in helix VI, mirrors the strong b-arrestin bias of ERG at 5-HT 2B receptors observed in pharmacological assays.
A likely structural explanation for the distinct conformational features and biased pharmacology of ERG between 5-HT 1B and 5-HT 2B receptors can be found in the region of the extracellular loop 2 (ECL2) junction with helix V.
In the 5-HT 2B receptor structure, E212-R213-F214 forms an additional helical turn stabilized by a structured water molecule at the extracellular tip of helix V (Fig. 5) . As a result, the segment of ECL2 that connect helices III and V via the conserved disulfide bond is shortened in the 5-HT 2B receptor, inducing an inward shift and creating a conformational constraint on the position of the extracellular tip of helix V. Because of these rearrangements, ERG forms additional hydrophobic contacts with M218 5.39 , L347 6.58 , V348 6.59 , L362 7.35 , and K211 ECL2 (M, Met; V, Val; K, Lys) ( fig. S8A ) and stabilizes a closer distance between helices V and VI, which form hydrophobic contacts between L219 5.40 , V348 6.59 , and L349 6.60 , along with a hydrogen bond between S222
5.43 and N344 6.55 (S, Ser) ( fig. S8B ). These extensive ligand-mediated interactions between helices V and VI in the 5-HT 2B /ERG complex may be inferred to prevent rearrangements in helix VI and the corresponding rotation of F 6.44 (8) , observed in the 5-HT 1B receptor and structures of other active-state GPCRs. The strengthened interactions of helix V and VI through ligand-mediated hydrogen bonds to both helices have also been linked to inhibition of G protein signaling at b 2 AR by the most efficacious inverse agonist (25) . S9 ). The tripeptide moiety of ERG appears to interfere with G protein signaling at the 5-HT 2B receptor, as ERG exhibits strongly increased b-arrestin signaling bias compared with LSD and MTE. Because both therapeutic (26) and adverse (27) drug effects have been associated with b-arrestin recruitment by GPCRs, identifying the features of biased GPCR states by known and yet to be discovered intracellular signaling proteins may facilitate the development of safer and more effective therapeutics with selective signaling profiles. 
